Compare CF Industries Holdings, Inc. (CF) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CF Industries Holdings, Inc. vs Mesoblast Limited — how do they compare? CF Industries Holdings, Inc. trades at $118.6 (market cap $18.58B), while Mesoblast Limited trades at $16.95 (market cap $2.09B). The key difference: CF Industries Holdings, Inc. is far larger — about 8.9× Mesoblast Limited's market cap, and CF Industries Holdings, Inc. pays a 1.98% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| CF | MESO | |
|---|---|---|
Market Cap | $18.58B | $2.09B |
Sector | Basic Materials | Technology |
52-Week High | $137.55 | $20.96 |
52-Week Low | $76.08 | $10.96 |
Enterprise Value | $20.15B | $2.10B |
Dividend Yield | 1.98% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CF Industries Holdings, Inc.
CF Industries is a leading producer and distributor of nitrogen fertilizers. The company operates seven nitrogen facilities in North America and holds joint venture interests in further production capacity in the United Kingdom and Trinidad and Tobago. CF makes nitrogen primarily using low-cost U.S. natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally.
Read more on CF →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
